SLXN

Biomotion Sciences Ordinary Shares

NASDAQ: SLXN · HEALTHCARE · BIOTECHNOLOGY

$0.58

-5.85% today

Updated 2026-06-05

Market cap

$1.28M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-59.70

Dividend yield

—

52W range

$2 – $224

Volume

7.0M

Market cap

$1.28M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-59.70

Dividend yield

—

52W range

$2 – $224

Volume

7.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.0

Quality

3.0

Profitability

5.0

Valuation

C+

5/9

Piotroski F-Score

Moderate

-15.2

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$60.00

+10262.69%

12-Month target

$2,373.81

+409884.46%

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Altman Z -15.16 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-3.65M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-3.21M	$-4.94M	$-16.44M	$-11.91M	$-2.73M
EPS	—	—	—	—	$-59.70
Free cash flow	$-3.38M	$-4.54M	$-8.42M	$-10.83M	$-3.65M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SLXN	$1.28M	18	4.3	3.0	5.0	4.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Biomotion Sciences Ordinary Shares trades at $0.58. Our Smart Value Score of 18/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -15.16, it sits in the distress.

Frequently asked questions

What is Biomotion Sciences Ordinary Shares's stock price?

Biomotion Sciences Ordinary Shares (SLXN) trades at $0.58.

Is Biomotion Sciences Ordinary Shares overvalued?

Biomotion Sciences Ordinary Shares carries a Smart Value Score of 18/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Biomotion Sciences Ordinary Shares (SLXN)?

The 12-month analyst consensus target is $60.00, about 10262.7% above the current $0.58. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Biomotion Sciences Ordinary Shares's Altman Z-Score is -15.16, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-897.00%

Beta-0.33

50D MA$7.19

200D MA$23.70

Shares out0.00B

Float0.00B

Short ratio—

Avg volume7.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

SLXN vs LLY →SLXN vs JNJ →SLXN vs ABBV →Stock screener →